Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.45 (USD) • At close December 23, 2024
Bedrijfsnaam Sensei Biotherapeutics, Inc.
Symbool SNSE
Munteenheid USD
Prijs 0.452
Beurswaarde 11,368,433
Dividendpercentage 0%
52-weken bereik 0.384 - 1.94
Industrie Biotechnology
Sector Healthcare
CEO Mr. John K. Celebi M.B.A., MBA
Website https://www.senseibio.com

An error occurred while fetching data.

Over Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment

Vergelijkbare Aandelen

Cardiff Oncology, Inc. logo

Cardiff Oncology, Inc.

CRDF

4.07 USD

Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc.

ALGS

38.85 USD

Reneo Pharmaceuticals, Inc. logo

Reneo Pharmaceuticals, Inc.

RPHM

18.2 USD

Cryo-Cell International, Inc. logo

Cryo-Cell International, Inc.

CCEL

7.73 USD

Vaccinex, Inc. logo

Vaccinex, Inc.

VCNX

1.31 USD

Daxor Corporation logo

Daxor Corporation

DXR

8.3 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)